DESCRIPTION: Reconcile Flavored Chewable Tablets for Dogs contain Fluoxetine Hydrochloride to treat separation anxiety symptoms. These once-daily tablets are intended to be used in conjunction with behavior modification, and they are approved by the FDA. They are also helpful in improving the dog's receptivity to behavior modification efforts.
Key Benefits:
Reconcile contains an SSRI called Fluoxetine Hydrochloride. It affects chemicals within an animal's body that can cause anxiety, depression, panic, and obsessive-compulsive behavior.
Formulated For: For puppies and dogs aged 8 weeks or older and at least 8.8lbs or more.
How is Medication Given? Recommended Doses for Puppies (8 Weeks and Up) and Dogs:
Dogs 8.8 to 17.6 Pounds: One Tablet (8 mg) Dogs 17.7 to 35.2 Pounds: One Tablet (16 mg) Dogs 35.3 to 70.4 Pounds: One Tablet (32 mg) Dogs 70.5 to 140.8 Pounds: One Tablet (64 mg) This medicationis used to treat separation anxiety in dogs (along with behavior modification). Recommended dosage rate is 1 mg to 2 mg for every kg of body weight (or 0.5 mg to 0.9 mg per pound) administered daily. Typically, behavior modification plans involve implementing training techniques that focus on teaching your dog how to be content independently, how to leave and return without eliciting an inappropriate response from your dog, and rewarding good behavior.
What Results Can I Expect? Reconcile:
Is non-sedative Helps with behavior modification to treat separation anxiety Reduces the frequency and severity of anxiety symptoms
What Form Does Medication Come In? Chewable Tablet
Dose and Administration: Each bottle contains 30 tablets in four weight-based strengths (8, 16, 32, or 64 mg).
Possible Side Effects: Potential side effects include:
Lethargy Decreased appetite Tremors Restlessness Depression Vomiting Diarrhea Seizures (which may occur in dogs with or without a history of epilepsy or seizures)
Precautions:
Do not use concomitantly with MAOIs, including selegiline hydrochloride (L-deprenyl) or amitraz, or within 2 weeks of MAOI treatment. A 6-week washout period should be observed after discontinuing treatment prior to using any medications that can react negatively with fluoxetine or norfluoxetine. Keep away from children and animals. Not for human use. Do not administer to dogs with epilepsy or a history of seizures. Do not administer concomitantly with medications that lower the seizure threshold, such as phenothiazines, acepromazine, or chlorpromazine. Do not administer to dogs who are hypersensitive to fluoxetine HCI or any other SSRI. Do not use to treat aggression.
Storage Recommendations: Keep product at room temperature between 20 degrees to 25 degrees C (68 degrees to 77 degrees F). Brief excursions of 59 degrees- 86 degrees F (15-30 degrees C) are permitted. Do not remove desiccant canister from bottle, keep bottle closed when not in use.
In Case of Overdose: Contact the nearest emergency pet clinic.
